Cargando…

Use of PCSK9 Inhibitor in a Mexican Boy with Compound Heterozygous Familial Hypercholesterolemia: A Case Report

We report on the case of an 8-year-old Mexican male, with a 3-year-old clinical diagnosis of familial hypercholesterolemia, and the difficulties encountered in his treatment while in our care. His treatment started with a regimen consisting of ezetimibe/simvastatin, cholestyramine, and a dietary pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceballos-Macías, José Juan, Madriz-Prado, Ramón, Vázquez Cárdenas, Norma Alejandra, Aguilar-Salinas, Carlos, Tusié-Luna, Maria Teresa, Flores-Real, Jorge Alberto, Ortega-Gutiérrez, Guillermo, Vargas-Sánchez, Joel, Lara-Sánchez, Carolina, Hernández-Moreno, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035209/
https://www.ncbi.nlm.nih.gov/pubmed/32104752
http://dx.doi.org/10.1210/jendso/bvz018